BioPharmSignal logoBioPharmSignal

Biotech News

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Outset Medical (OM)Outset MedicalEarnings

SAN JOSE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter 2026

Related news

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

ICUSeaStar Medical2026-08-06 12:35 EST

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

IRIXIRIDEX2026-08-04 20:05 EST

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

DNLIDenali Therapeutics2026-07-27 20:01 EST

Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

TMCITreace Medical Concepts2026-07-24 11:05 EST

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

CVRXCVRx2026-07-23 20:30 EST

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

SGHTSight Sciences2026-07-22 20:05 EST

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

STXSStereotaxis2026-07-21 13:00 EST

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

IRTCiRhythm2026-07-16 20:05 EST

iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026

PRCTPROCEPT BioRobotics2026-07-14 20:05 EST

PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026

View all latest news

Outset Medical

Dialysis Technology Outset Medical develops technology intended to simplify dialysis delivery across hospitals, clinics and home-care settings. Tablo Hemodialysis System Tablo is an integrated hemodialysis system that combines water purification, on-demand dialysate production and treatment delivery in a single device. Its design seeks...

Recent company news

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

OMOutset Medical2026-07-23 13:00 EST

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

OMOutset Medical2026-07-02 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-05-21 20:05 EST

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-05-11 20:05 EST

Outset Medical to Present at RBC Global Healthcare Conference

Stock data

Close
5.20 USD
Market cap
93.98M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States